Current QIMR Berghofer appointment
- Team Head, Health Economics group, QIMR Berghofer.
Associate Professor Louisa Gordon is a mid-career researcher with 15 years’ experience as a health economist and public health researcher. Her research is focused on economic evaluation, economic modelling, statistical analysis of cost data, study design and research methods for health economics.
Over the past six years she has been chief investigator on competitive research grants totalling over $5 million from the NHMRC & ARC and on research consultancies totalling over $5.2 million including reports to decision-makers at the Department of Health. Her research addresses the societal cost of health issues and the cost-effectiveness of health interventions and technologies.
In 2017, Louisa was awarded $480,000, 18-months funding from the Queensland Genomic Health Alliance to lead the Evaluation of Clinical Genomics workstream capability. This involves building evaluation activities into four clinical demonstration projects which will implement genomic testing in various patient groups and develop a framework for valuing clinical genomics.
During the course of her research career, she has worked on projects covering a wide range of health issues such as:
- behaviour change interventions during cancer survivorship
- genetic testing
- work loss following colorectal cancer
- nursing interventions for improving patient care
- the economics of ultraviolet radiation on health.
During this work, Louisa has collaborated widely with clinicians and health policymakers to facilitate translation of research outcomes and communicate these to relevant stakeholders.
For modelling work, she uses various computer software including Stata, TreeAge Pro and AnyLogic simulation package.
Other current appointments
- Adjunct Associate Professor, School of Nursing, QUT
- Adjunct Associate Professor, School of Medicine, UQ
- Principal Research Fellow, Griffith University
- NHMRC Post-doctoral Research Fellow, QIMR Berghofer
- Health Economist, Cancer Council Queensland
Current Area of Research
- Economic evaluation
- Decision-analytic modelling
- Cancer interventions
- Evaluation of clinical genomics projects in Queensland
- Pilot evaluation of the Nurse Navigator program in Queensland Health
- Using a hybrid simulation model to examine a risk assessment tool to improve triaging patients referred for colonoscopies
- Within-trial cost-effectiveness analysis of a decision aid and DVD information support for men diagnosed with low-risk prostate cancer
- Costs of Surviving Cancer – a Queensland study (COS-Q)
- Pilot evaluation of the transplant skin clinic project
- Queensland Genomics Health Alliance CI Gordon LG, Co-investigators: Graves N, Webb P, Lakhani S, Griffiths L, Spurdle A, Waddell N, Schofield D, Shrestha R, Cunich M, Khurshid A, Tan O, Rynehart L, Lymer S, West S. Evaluation of Clinical Genomic Projects in Action in Queensland. 2017-2018, $480,000.
- Australian Red Cross Blood Service Gordon L. ‘Economic analysis of RHD genotyping to target pregnant women for antenatal and post-partum anti-D prophylaxis ($20,000).
- NHMRC Project Grant #1079720 – Schofield P, Chambers SK, Juraskona I, Gordon LG, Gardiner F. ‘ASTROID: Active Surveillance and other TReatment OptIons for prostate cancer. An RCT of decision aid and DVD information support for men diagnosed with low-risk prostate cancer.’ 2015-2018 ($749,704).
- NHMRC Project Grant #1041640 JTurner, Fraser A, McCarthy A, Gordon L Hughes B, Burmeister B, Thomson D, Skerman H, Carswell K, Basone M, Yates P, Chan R. Improving quality of life in high-risk cancer populations: a RCT of an intervention for head and neck cancer survivors. 2013-2015 ($476,074).
- NHMRC Project Grant #1029613 Flenady V, Gardener G, Wilson P, Cooke L, Gordon A, Ellwood D, Alison K, Charles A, Khong Y, Teale G, Morris J, Coory M, Gordon L, Thomas S, Dennis A, Jennings B, Sullivan E. Investigating causes of stillbirths: a prospective cohort study examining use and effectiveness of a comprehensive investigation protocol. Mater Medical Research Institute Ltd ($554,506).
- Gordon LG, Brynes J, Baade PD, Neale RE, Whiteman DC, Youl PH, Aitken JF, Janda M. Cost-effectiveness analysis of a skin awareness intervention for early detection of skin cancer targeting men over 50 years. Value Health. 2017 Apr;20(4):593-601. doi: 10.1016/j.jval.2016.12.017
- Gordon LG, Merollini K, Lowe A, Chan R. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. The Patient: Patient-Reported Outcomes Research. 2017: 10: 295.
- Donovan P, McLeod D, Little R, Gordon LG. Cost-Utility Analysis Comparing Radioactive Iodine, Antithyroid Drugs and Total Thyroidectomy for Primary Treatment of Graves’ Disease. Euro J Endocrinology 2016: 175 (6) 595-603.
- Gordon LG, James R, Tuffaha H, Lowe A, Yaxley J. Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. J Med Resonance Imaging 2017 May;45(5):1304-1315 doi: 10.1002/jmri.25504
- Gordon LG, DiSipio T, Battistutta D, Yates P, Bashford J, Pyke C, Eakin E, Hayes SC. Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized, controlled trial. Psycho-Oncology 2017 May;26(5):649-655.
- Tuffaha HW, Roberts S, Chaboyer W, Scuffham PA, Gordon LG. Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high risk hospitalised patients. Advances in Skin and Wound Care. 2016 Jun;29(6):261-7.
- Gordon LG, Elliott TM, Wright CY, Deghaye N, Visser W. Modelling the healthcare costs of skin cancer in South Africa. BMC Health Services Research 2016 Apr 2;16(1):113.
- Tuffaha HW, Gordon LG, Scuffham PA .Value of information analysis informing adoption and research decisions in a portfolio of healthcare interventions. Med Dec Making – Policy & Practice (Accepted 3/3/16).
- Gordon LG, Bartley N. Views from senior Australian cancer researchers on evaluating the impact of their research: results from a brief survey. Health Research Policy and Systems. 2016;14(1):2.
- McGrath C, Mihala G, Beesley VL, Lynch BM, Graves N, Gordon LG. “Cancer put my life on hold”: work-related challenges among middle-aged adults 12 months after a diagnosis of colorectal cancer. Cancer Nursing (Accepted 8/12/15)
- Chambers SK, Scuffham PA, Baade PD, Lowe AP, Dunn J, Galvao DA, Gordon LG, Smith DP, Sandoe DF, Wootten AD, Spry NA, Gardiner RA, Davis ID, Newton RU. Advancing prostate cancer survivorship research in Australia. Cancer Forum, 2015: 39 (3): 204-209.
- Gordon LG, Walker SM, Mervin CM, Lowe A, Smith DP, Gardiner RA, Chambers SK. Financial toxicity: a potential side-effect of prostate cancer treatment among Australian men. Euro J Cancer Care, 2015 Oct 1. doi: 10.1111/ecc.12392
- Gordon LG, Patrao T, Kularatna S, Hawkes AL. A telephone-delivered multiple health behaviour change intervention for colorectal cancer survivors: making the case for cost-effective health care’ Euro J Cancer Care, 2015; 24(6) 854-861.
- Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J, Eslick G, Gordon LG, …. Watson DI, Yusoff IF. Australian clinical practice guidelines for the diagnosis and management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. J Gastroenterol Hepatol, 2015, 30(5), 804-820.
- Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review Euro J Cancer Prevention 2015, 24(2), 141-149.
- Gordon LG, Beesley VL, Lynch BM, Mihala G, McGrath C, Graves N, Webb PM. The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study. BMC Public Health. 2014, 14(1), 963.
Publication summary: Of 134 career publications, 96 are journal publications including papers in Br J Surg, JAMA Dermatol, Ann Oncol, J Invest Dermatol, Value Health and 58 of the journal publications are in the last 5 years (from 2013). For the Department of Health, I have overseen or led 30 major reports for MSAC and PBAC. I have presented at 35 conferences (3 keynote talks & 5 invited speaker talks) and written 2 chapters in Australian clinical practice guidelines (and 1 more pending).
- Lead a systematic review of financial toxicity among cancer survivors – published in The Patient – Patient-Centred Outcomes Research 2017; 1-15. This was an invited article where I am seen as a leader on this topic. It has received much attention and support by psychosocial health researchers and 15 citations in the first 9 months of publication.
- Contributed to Australian clinical practice guidelines for the diagnosis and management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. This has been disseminated via Cancer Australia online networds and published in J Gastroenterol Hepatol. 2015; 30(5)804-820. 32 citations. This guidelines paper was the result of a working party of clinicians and researchers specifically designed to influence clinical practice in this field in Australia and internationally.
- Lead a systematic review on the health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening – published in European Journal of Cancer Prevention 2015; 21(2),141-149. 45 citations This is the first review of the economic evidence of skin cancer globally and was repeatedly quoted and highlighted at the 3rd International Conference in UV and Skin Cancer Prevention.I was asked to present this at a WHO meeting (remotely) in Belgium 2016.
- During 2007-2008, published a major report and several publications later on the harms of solaria use in Australia and economic impacts of regulation. This body of work contributed to legislation passed in all State parliaments of Australia which now bans the use of commercial solaria businesses.
- 2017 – current: Queensland Collaborative for Cancer Survivorship www.qccs.org.au
- 2017 – current: BDHP theme ‘Evidence & Innovation in Clinical Care’ http://www.brisbanediamantina.com/
- 2017 – current: Health Services Research Association of Australia and New Zealand
- 2013 – current: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Aust. Chapter.
- 2008 – current: International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
- 2013: International Health Economics Society.
- 2007: Psycho-Oncology Cooperative Research Group.
- 2015: Vice Chancellors Research Excellence Award for a Team $10,000, Griffith University.
- 2015 and 2011: Pro Vice Chancellors (Health) Research Excellence Award for a Team $10,000, Griffith University.
- 2015: 1st Place Poster Award at Prostate Cancer World Congress (Clinical Urology).
- 2013: Griffith University International Travel Fellowship $5,000.
- 2013: Griffith University Publication of the Year, Population and Social Health Research Program $1,000.
- 2008: Certificate of Exemplary Service – Cancer Council Australia (for commitment to revision and development of the Australian Cancer Network’s Basal Cell Carcinoma, Squamous Cell Carcinoma (and Related Lesions) – A Guide to Clinical Management in Australia’.
- 2008 – 2012: NHMRC Public Health Early Career Fellowship #496714.
- PhD (Public Health), Queensland University of Technology.
- Master of Public Health, Queensland University of Technology.
- Bachelor of Economics (Economics major) University of New England.